We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Boston Scientific to Market Angioplasty Device

By HospiMedica staff writers
Posted on 07 Oct 2003
Following a series of agreements, exclusive global distribution rights to a new angioplasty device have been acquired by Boston Scientific Corp. More...
(Natick, MA, USA) from CryoVascular Systems, Inc. (Los Gatos, CA, USA).

The device, designed to treat atherosclerotic disease of the legs and peripheral arteries, has been cleared by the US Food and Drug Administration (FDA) and has received the CE Mark. The device is based on new technology developed by CryoVascular called PolarCath, which utilizes liquid nitrous oxide to provide precise freezing of diseased arteries during balloon angioplasty. The procedure is designed to reduce the rate of restenosis, which often requires patients to have angioplasty again. Current balloon angioplasty and stent technology have a high rate of repeat procedures, reported to be as high as 45%.

A post-market clinical study of the new device is now under way. Boston Scientific's agreement with CryoVascular also includes the right to make an equity investment in the company and an option to acquire the company in the future.

"We are excited about the early trial results of the CryoPlasty procedure, which suggest improved outcomes in challenging cases,” said Paul LaViolette, senior vice president and group president, cardiovascular, at Boston Scientific. "Boston Scientific is continually searching for innovative ways to treat patients suffering from peripheral vascular disease.”



Related Links:
Boston Scientific
CryoVascular

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.